Independent prognostic value of the 67-kd laminin receptor in human prostate cancer

Journal of the National Cancer Institute

Volumn 89, Issue 16, 1997, Pages 1224-1227

  Waltregny, David ^a   De Leval, Laurence ^a   Ménard, Sylvie ^b   De Leval, Jean ^a   Castronovo, Vincent ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LAMININ RECEPTOR;

ANTIGEN EXPRESSION; ARTICLE; BONE METASTASIS; CANCER STAGING; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CANCER;

EID: 0030742338     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/89.16.1224     Document Type: Article

References (40)

1. Lerner SE, Seay TM, Blute ML, Bergstralh EJ, Barrett D, Zincke H. Prostate specific antigen detected prostate cancer (clinical stage T1c): an interim analysis. J Urol 1996;155: 821-6.
2. Oesterling JE, Suman VJ, Zincke H, Bostwick DG. PSA-detected (clinical stage T1c or B0) prostate cancer. Pathologically significant tumors. Urol Clin North Am 1993;20: 687-93.
3. Epstein JI, Walsh PC, Carmichael M, Brendler CB. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 1994;271: 368-74.
4. Catalona WJ, Smith DS, Ratliff TL, Basler JW. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA 1993;270: 948-54.
5. Smith DS, Catalona WJ. The nature of prostate cancer detected through prostate specific antigen based screening. J Urol 1994;152: 1732-6.
6. Stamey TA, Kabalin JN, McNeal JE, Johnstone IM, Freiha F, Redwine EA, et al. Prostate-specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients. J Urol 1989;141:1076-83.
7. Paulson DF, Moul JW, Walther PJ. Radical prostatectomy for clinical stage T1-2N0M0 prostatic adenocarcinoma: long-term results. J Urol 1990;144:1180-4.
8. Oesterling JE, Chan DW, Epstein JI, Kimball AW Jr, Bruzek DJ, Rock EC, et al. Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. J Urol 1988;139:766-72.
9. Walsh PC, Lepor H. The role of radical prostatectomy in the management of prostatic cancer. Cancer 1987;60(3 Suppl):526-37.
10. (1O) Timpl R, Rohde H, Robey PG, Rennard SI, Foidart JM, Martin GR. Laminin - a glycoprotein from basement membranes. J Biol Chem 1979;254:9933-7.
11. Timpl R, Engel J, Martin GR. Laminin: a multifunctional protein of basement membranes. Trends Biochem 1983;8:207-9.
12. Kleinman HK, Cannon FB, Laurie GW, Hassell JR, Aumailley M, Terranova VP, et al. Biological activities of laminin. J Cell Biochem 1985;27:317-25.
13. Engel J, Odermatt E, Engel A, Madri J, Furthmayr H, Rohde H, et al. Shapes, domain organizations and flexibility of laminin and fibronectin, two multifunctional proteins of the extracellular matrix. J Mol Biol 1981;150: 97-120.
14. Terranova VP, Liotta LA, Russo RG, Martin GR. Role of laminin in the attachment and metastasis of murine tumor cells. Cancer Res 1982;4:2265-9.
15. Malinoff HL, McCoy JP Jr, Varani J, Wicha MS. Metastatic potential of murine fibrosarcoma cells is influenced by cell surface laminin. Int J Cancer 1984;33:651-5.
16. Barsky SH, Rao CN, Williams JE, Liotta LA. Laminin molecular domains which alter metastasis in a murine model. J Clin Invest 1984;74:843-8.
17. Castronovo V. Laminin receptors and laminin-binding proteins during tumor invasion and metastasis. Invasion Metastasis 1993;13: 1-30.
18. Rao NC, Barsky SH, Terranova VP, Liotta LA. Isolation of tumor cell laminin receptor. Biochem Biophys Res Commun 1983;111: 804-8.
19. Kleinman HK, Ogle RC, Cannon FB, Little CD, Sweeney TM, Luckenbill-Edds L. Laminin receptors for neurite formation. Proc Natl Acad Sci U S A 1988;85:1282-6.
20. Castronovo V, Taraboletti G, Liotta LA, Sobel ME. Modulation of laminin receptor expression by estrogen and progestins in human breast cancer cell lines. J Natl Cancer Inst 1989;81:781-8.
21. Wewer UM, Taraboletti G, Sobel ME, Albrechtsen R, Liotta LA. Role of laminin receptor in tumor cell migration. Cancer Res 1987;47:5691-8.
22. Martignone S, Menard S, Bufalino R, Cascinelli N, Pellegrini R, Tagliabue E, et al. Prognostic significance of the 67-kilodalton laminin receptor expression in human breast carcinomas. J Natl Cancer Inst 1993;85: 398-402.
23. Daidone MG, Silvestrini R, D'Errico A, Di Fronzo G, Benini E, Mancini AM, et al. Laminin receptors, collagenase IV and prognosis in node-negative breast cancers. Int J Cancer 1991;48:529-32.
24. Pellegrini R, Martignone S, Tagliabue E, Belotti D, Bufalino R, Cascinelli N, et al. Prognostic significance of laminin production in relation with its receptor expression in human breast carcinomas. Breast Cancer Res Treat 1995;35:195-9.
25. Mafune K, Ravikumar TS, Wong JM, Yow H, Chen LB, Steele GD Jr. Expression of a Mr 32,000 laminin-binding protein messenger RNA in human colon carcinoma correlates with disease progression. Cancer Res 1990;50:3888-91.
26. Cioce V, Castronovo V, Shmookler BM, Garbisa S, Grigioni WF, Liotta LA, et al. Increased expression of the laminin receptor in human colon cancer. J Natl Cancer Inst 1991;83:29-36.
27. Campo E, Monteagudo C, Castronovo V, Claysmith AP, Fernandez PL, Sobel ME. Detection of laminin receptor mRNA in human cancer cell lines and colorectal tissues by in situ hybridization. Am J Pathol 1992;141: 1073-83.
28. D'Errico A, Garbisa S, Liotta LA, Castroinno V, Stetler-Stevenson WG, Grigioni WF. Augmentation of type IV collagenase. laminin receptor, and ki67 proliferation antigen associated with human colon, gastric, and breast carcinoma progression. Mod Pathol 1991;4:239-46.
29. van den Brule FA, Castronovo V, Menard S, Giavazzi R, Marzola M, Belotti D, et al. Expression of the 67 kD laminin receptor in human ovarian carcinomas as defined by a monoclonal antibody, MLuC5. Eur J Cancer 1996;32A:1598-602.
30. Demeter LM, Stoler MH, Sobel ME, Broker TR, Chow LT. Expression of high-affinity laminin receptor mRNA correlates with cell proliferation rather than invasion in human papillomavirus-associated cervical neoplasms. Cancer Res 1992;52:1561-7.
31. Pellegrini R, Martignone S, Menard S, Colnaghi MI. Laminin receptor expression and function in small-cell lung carcinoma. Int J Cancer 1994;Suppl 8:116-20.
32. Satoh K, Narumi K, Isemura M, Sakai T, Abe T, Matsushima K, et al. Increased expression of the 67kDa-laminin receptor gene in human small cell lung cancer. Biochem Biophys Res Commun 1992;182:746-52.
33. Basolo F, Pollina L, Pacini F, Fontanini G, Menard S, Castronovo V, et al. Expression of the 67 KD laminin receptor is an adverse prognostic indicator in human thyroid cancer: immunohistochemical study. Clin Cancer Res 1996;2:1777-80.
34. Grigioni WF, Garbisa S, D'Errico A, Baccarini P, Stetler-Stevenson WG, Liotta LA, et al. Evaluation of hepatocellular carcinoma aggressiveness by a panel of extracellular matrix antigens. Am J Pathol 1991;138: 647-54.
35. Schroder FH, Hermanek P, Denis L, Fair WR, Gospodarowicz MK, Pavone-Macaluso M. The TNM classification of prostate cancer. Prostate Suppl 1992;4:129-38.
36. Mariani-Constantini R, Barbanti P, Colnaghi MI, Menard S, Clemente C, Rilke F. Reactivity of a monoclonal antibody with tissues and tumors from the human breast. Immunohistochemical localization of a new antigen and clinicopathologic correlations. Am J Pathol 1984;115:47-56.
37. Menard S, Tagliabue E, Canevari S, Fossati G, Colnaghi MI. Generation of monoclonal antibodies reacting with normal and cancer cells of human breast. Cancer Res 1983;43: 1295-300.
38. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
39. Cox DR. Regression models and life tables. J R Stat Soc 1972;34:187.
40. Gleason DF, Mellinger GT. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 1974;111:58-64.